Fig. 3 SLRPs are enriched in human brain lesions.
Anti-CHAD, anti-FMOD, anti-LUM, and anti-PRELP immunoreactivity is locally increased in areas of scarring caused by contusion, local hemorrhage, or previous surgery (asterisks indicate lesion center, arrowheads mark scar boundaries) in the human brain, as compared to regions distant to the primary lesion site (hash sign), as well as human brain controls with no signs of fibrotic scarring (see Supplementary Fig.